Physician profile
Nicholas Morrow
NPI 1336573757
$535.85
in general payments reported to CMS, 2019-2025
9 companies · $42.65 in 2025
The $42.65 reported for 2025 was less than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $162 · 2023: $170 · 2024: $161 · 2025: $42.65.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $374.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $374.08 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Otsuka America Pharmaceutical, INC. | $223.34 | 2023-2025 | Rexulti, Nuedexta |
| Astrazeneca Pharmaceuticals LP | $149.94 | 2021-2023 | Lokelma |
| Mylan Specialty L.P. | $49.99 | 2023 | Yupelri |
| Viatris Specialty LLC | $27.53 | 2025 | Yupelri |
| Sumitomo Pharma America, INC. | $24.27 | 2023 | Gemtesa |
| Abbvie INC. | $18.27 | 2023 | |
| Biogen, INC. | $16.54 | 2021 | |
| Allergan, INC. | $13.13 | 2021 | |
| Lundbeck LLC | $12.84 | 2023 | Rexulti |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nicholas Morrow listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.